| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |